NuCana plc
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
NCNA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US67022C2052
- LEI:
- Country:
- United States of America
- Address:
- 3 LOCHSIDE WAY, EDINBURGH
- Website:
- https://www.nucana.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NuCana plc is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. The company utilizes its proprietary ProTide technology, which is based on phosphoramidate chemistry, to develop more effective and safer anti-cancer medicines. This approach is designed to overcome key cancer cell resistance mechanisms, aiming to enhance the efficacy of widely prescribed chemotherapies and immunotherapies. NuCana's development pipeline targets a broad range of cancers, with the mission to pioneer a new era in oncology and improve patient survival outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NuCana plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NuCana plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NuCana plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
